← Leaderboards
Aasthaa Bansal
University Of Washington
$3,195,862
Attributed
$3,195,862
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $492.1K · FY2017–24$500K$375K$250K$125K$0
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$3,195,862 · 2
By mechanism
R37$3,040,591 · 1
R03$155,271 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Washington
Same institution · by research overlap
- Kenneth Sherr$9,300,980
- Stephen J Salipante$5,477,355
- Jillian Pintye$10,948,659
- Margaret A Hannon$27,495,073
- John Chris Feudtner$9,337,484
Others in their field
Other Emerging Leaders on “Complex”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Chanza Baytop · Westat, Inc.$271,217,917
- Leonard Freedman · Leidos Biomedical Research, Inc.$58,784,651
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$41,535,815
- John Hobbs · Suny At Stony Brook$41,239,084
Research focus
ComplexPoliciesFutureGuidelinesFaceBiological MarkersDisease ProgressionDecision MakingCollectionComparative EffectivenessCost OutcomesCancer SurvivorCostCouplingCohort StudiesDisease RemissionClinic VisitsChronic Myeloid LeukemiaFollow-UpClinical ManagementColorectal CancerColorectal Cancer ScreeningCancer RecurrenceFrequencies
Grant awards (9)
Personalized Risk-AdaptIve Surveillance (PRAISE) - Implications of Algorithmic Bias$423,669
R37 · FY2024 · CA · contact PI
Personalized Risk-AdaptIve Surveillance (PRAISE) - Implications of Algorithmic Bias$440,450
R37 · FY2023 · CA · contact PI
Personalized Risk-AdaptIve Surveillance strategies in cancEr -- PRAISE$419,114
R37 · FY2022 · CA · contact PI
Personalized Risk-AdaptIve Surveillance strategies in cancEr -- PRAISE$444,555
R37 · FY2021 · CA · contact PI
Personalized Risk-AdaptIve Surveillance strategies in cancEr -- PRAISE$449,314
R37 · FY2020 · CA · contact PI
Personalized Risk-AdaptIve Surveillance strategies in cancEr -- PRAISE$449,121
R37 · FY2019 · CA · contact PI
Personalized Risk-AdaptIve Surveillance strategies in cancEr -- PRAISE$414,368
R37 · FY2018 · CA · contact PI
Disparities in the Availability of Cancer Clinical Trials: A Multi-level Analysis$77,750
R03 · FY2018 · CA · contact PI
Disparities in the Availability of Cancer Clinical Trials: A Multi-level Analysis$77,521
R03 · FY2017 · CA · contact PI